ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer
The objective of this study is to evaluate the clinical effectiveness and safety of treatment of prostate cancer in patients who have received a focal HIFU treatment using the Focal One medical device.
Prostate Cancer
DEVICE: FocalOne
Evaluation of adverse events, using the Clavien-Dindo classification, 1 year|Evaluation of quality of life, IQL questionnaires, 3, 6, 9 and 12 months|Evaluation of urinary incontinence, ICIQ questionnaire, 3, 6, 9 and 12 months|Erectile function assessment, IIEF-5 questionnaire, 3, 6, 9 and 12 months|Urinary Symptoms, IPSS questionnaire, 3, 6, 9 and 12 months
The objective of this study is to evaluate the clinical effectiveness and safety of treatment of prostate cancer in patients who have received a focal HIFU treatment using the Focal One medical device.